AcroCyte Therapeutics Inc. is revolutionizing precision medicine through R3CE® (Rapid, Reproducible, Rare Cell 3D Expansion)—the world's only technology that successfully cultures CTCs (Circulating Tumor Cells) from blood and creates personalized 3D cell cultures from any tissue specimen in a week. Our breakthrough eliminates the need for traditional cell lines and animal testing, empowering patients to access truly personalized treatments using their own cells. Through our Onco-REAL™ clinical service, we're transforming cancer care with precise, patient-specific solutions.

AcroCyte Therapeutics

Org chart

Teams

Offices

Similar companies